Filters
Information shared on social media—whether official or not, scientific or not—shape beliefs regarding the novel coronavirus disease (COVID-19), according to a new study.
Patients with severe imported malaria appear to fare well with intravenous artesunate, despite an increased incidence of mild-to-moderate post-treatment delayed haemolysis, as reported in a study.
Influenza infection appears to be a risk factor for systemic lupus erythematosus flares needing hospitalization, independently of patient age, sex, and comorbidities, a recent study has found.
The body is capable of mounting a humoral immune response with functional cross-reactivity against the D614G variant of SARS-CoV-2, claims a recent Singapore study.
Patients with severe asthma receiving treatment with biologics are more likely to contract COVID-19 and develop a severe course as compared with the general population, a study has found.
The National COVID-19 Immunisation Programme has announced “high-risk group with chronic diseases” is priority group 2 in Phase 2 and will be vaccinated in April-August 2021.
As the Hong Kong government launches a territory-wide coronavirus disease 2019 (COVID-19) vaccination programme, the Chinese University of Hong Kong (CUHK) and the University of Hong Kong (HKU) have shared findings of their independent telephone surveys gauging public views of the programme.
Around 2 percent of people seeking post-exposure prophylaxis (PEP) eventually test positive for HIV within 4 years, a recent study has found. This trend is particularly pronounced among men who have sex with men (MSM), strongly suggesting the potential for the early consideration of pre-exposure prophylaxis (PrEP) after a first episode of PEP.
Patients with the novel coronavirus disease (COVID-19) are prone to gastrointestinal (GI) symptoms, which appears to predict a better prognosis, suggests a single-centre cohort study in Northern Italy.
A recent modelling study has found that expanding current pre-exposure prophylaxis (PrEP) programmes and improving adherence rates can substantially lower HIV incidence among men who have sex with men (MSM).
